Default company panoramic image

Bio-Signal Group Corp.

BSG's microEEG technology --miniature, easy to use, disposable -- revolutionizes brain monitoring for the ER and other points of care.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location NY, USA
  • Currency USD
  • Founded June 2002
  • Employees 8
  • Website

Company Summary

BSG provides a rapid, easy-to-use EEG system (microEEG) which allows for functional brain monitoring in new points of care (ie. the ER, a 12.4M patient market p.a.); and transforms EEG in existing settings such as neurology practices. microEEG, proven in multiple clinical trials, has received FDA 510(k) clearance and over $5.5M in NIH funding, and eliminates the need for an EEG technician and allows for remote neurologist interpretation of EEG.


  • Default avatar
    Kathleen M Plath
    Chief Executive Officer

    High energy, leading sales and marketing professional with experience growing start-up and new business ventures across a variety of industries including healthcare, government, and technology services. Experience includes national and major account program development and management, new business development, customer relationship management, and sales force automation.

  • Default avatar
    Samah Abdul Baki
    Chief Medical Officer

    Samah Abdel Baki, MD is the Chief Medical Officer at BSG. He brings 4 years of clinical practice in the Emergency Department as well as a strong background in research to the BSG team. His research establishing a multi-drug regimen to treat cognitive deficits post experimental traumatic brain injury has been cited by the US Army as one of the most outstanding research projects funded by the Congressionally Directed Medical Research Programs.

  • Default avatar
    Andre Fenton

    André Fenton (PhD), a BSG founder and the President, is Professor of Neural Science at the Center for Neural Science at New York University. Recently, Dr. Fenton used BSG’s ITS (Interactive Tracking System) to identify PKMζ as the first molecular mechanism of long-term memory storage (Pastalkova et al., 2006). This work was recognized by Science as one of 10 major breakthroughs in 2006.


  • Default avatar
    Lowenstein Sandler
    Default avatar
    Marks Paneth & Shron

Previous Investors

  • Default avatar
    Business angels including a) CEO of major investment bank for
    Default avatar
    Germany, Austria and Switzerland; b) hedge fund portfolio managers:
    Default avatar
    c) major technology law firm founding partner; and others.